Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Ekf Diagnostics Holdings Plc LSE:EKF London Ordinary Share GB0031509804 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.20 2.89% 78.20 78.40 80.20 80.00 78.20 80.00 187,232 12:11:17
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 44.9 5.5 0.8 96.5 356

Ekf Diagnostics Share Discussion Threads

Showing 2926 to 2948 of 3375 messages
Chat Pages: Latest  123  122  121  120  119  118  117  116  115  114  113  112  Older
DateSubjectAuthorDiscuss
08/1/2021
07:42
As previously mentioned, although Covid-19 testing is in ever greater demand, as EKF investors, we do also need to cast our eye beyond Covid-19 testing, especially now that Longhorn, and indeed EKF, has been put firmly on the testing/surveillance map. In this regard Longhorn Vaccines already have a screening test for TB. So, to highlight the importance (and size) of the TB market, I was interested to note that yesterday (US time) PerkinElmer announced it is to acquire Oxford Immunotec Global PLC - Through this Acquisition, PerkinElmer will grow its portfolio of advanced infectious disease testing solutions to include tuberculosis detection to better serve customers around the world. hTTps://investor.oxfordimmunotec.com/news-releases/news-release-details/perkinelmer-acquire-oxford-immunotec-global-plc
wan
08/1/2021
07:19
Source Bio now offer Government approved 'Test to Release' Covid-19 Antigen RT-PCR tests. You can reduce your self isolation time when arriving back from your holiday or business trip. Order online: hTTps://coviduk.sourcebioscience.com/?utm_source=linkedin&utm_medium=_&utm_term=source+bioscience&utm_content=e5c5bc23-d4bf-4dd8-92b0-50cd9e625cdb&utm_campaign=default+post
wan
08/1/2021
07:12
7th January 2021 EKF fly the extra mile over Christmas EKF fly the extra mile over Christmas PrimeStore - EKF fly the extra mile over Christmas 3 Like Santa, the EKF Diagnostics logistics team took to the skies over the Christmas holidays. Faced with the problem of sending 160,000 tubes of PrimeStore MTM to a customer in Ireland with a tight deadline and the uncertainty around border control due to the Brexit negotiations, the team at EKF’s Barleben facility charted an aircraft and flew 18 pallets directly to Dublin Airport. Thanks to the efficiency of our team and their colleagues at DB Schenker the consignment reached Dublin within three hours, ready to be collected by our distributor, Syntec. hTTps://www.ekfdiagnostics.com/ekf-fly-the-extra-mile-over-christmas.html
wan
06/1/2021
19:25
Petewy- Dont know about you but what I really enjoy about investing in small caps such as EKF & those others you listed is that by carrying out fundamental research you can take up a position in the stock well before “Mr Market” - in this case Liontrust- belatedly cottons on/is able to take up a significant position. As Peter Lynch said, “when a company I talk to tells me the last analyst showed up 3 years ago, I can hardly contain my enthusiasm”.
firtashia
06/1/2021
18:06
Because you're a fathead old chap Toodle pip
chris16041
06/1/2021
18:06
Because you're a fathead old chap Toodle pip
chris16041
06/1/2021
16:32
Funny following I have - I wonder why.
tongosti
06/1/2021
16:09
Agreed Riv I made money with Techinvest, very thorough. Filter Tong MG he's a nuisance on SDI MWE and JET2
petewy
06/1/2021
15:53
Haha - my fav village in chief!
tongosti
06/1/2021
15:50
If anyone wants to check the credibility of this Tong poster please see the SDI BB and my recent exchange exposing his lies there
mg1982
06/1/2021
15:37
My 920 post on this board posted precisely 56 days ago chaps: 09:06 Odds for a meaningful (at least) major consolidation (or worse!) around existing levels have risen to 93% including last Friday's data.Fair to say that two months down the line this has come to pass ain't it. Now the question is - what is the next path of least resistance? I am flat but willing to go back long IF Mr Market gives me a hint. Until he does so - relaxing and biding my time.
tongosti
06/1/2021
15:18
Indeed. I posted it there since it was relevant to ORPH (and CNIC too) as well as EKF. Techinvest is imo an excellent tip sheet, one of if not THE best around along with SCSW. Their portfolios over many years have performed outstandingly well overall. If they were to buy EKF for their portfolio it would likely result in additional interest here. Which is never a bad thing. Apologies to others here for having to post this!
rivaldo
06/1/2021
13:57
You also posted this on the Orph site Rivaldo. It's just a perennial tip sheet as old as me.
faz
06/1/2021
09:00
So no doubt readers will no get my drift with regards to the recent investment fund purchases in EKF!
wan
06/1/2021
08:51
Faz...I agree, but I also assume a fund manager might also explore that avenue too, which is what EKF implied in relation to the sale of Renalytix shares stating "in response to strong institutional demand". My guess, apart from the individual and general investment rationale, is that there needs to be something 'material' left for the new owners. In this regard, and only as a 'possible' example, it's worth considering Renalytix news yesterday to get my drift. I have used this 'perceived' situation as a mere PI to my advantage, which doesn't always come around quite so soon. In this regard though, I am still expecting more to come from Renalytix!
wan
06/1/2021
08:33
Thanks, yes it must something specific to those links, but managed to effectively use an original article link
wan
06/1/2021
08:14
Try [...] or hTtps://www.tesco.com/groceries/en-GB/search?query=port Yes - seems to be that particular site so you will just have to reconstitute: htTps://www dot thelancet.com/journals/laninf/article/PIIS1473-3099(20)30859-8/fulltext
sharw
06/1/2021
08:06
Test - [...]
wan
06/1/2021
08:01
Apologies, currently links won't post, ADVFN may have changed something!
wan
06/1/2021
07:55
Potential for making a difference! Longhorns' President highlighted the following; PrimeStore MTM combined with the GeneXpert enables safe testing of Aboriginal and Torres Strait Islander communities across Australia - Published online December 23, 2020 A decentralised point-of-care testing model to address inequities in the COVID-19 response The COVID-19 pandemic is growing rapidly, with over 37 million cases and more than 1 million deaths reported by mid-October, 2020, with true numbers likely to be much higher in the many countries with low testing rates. Many communities are highly vulnerable to the devastating effects of COVID-19 because of overcrowding in domestic settings, high burden of comorbidities, and scarce access to health care. Access to testing is crucial to globally recommended control strategies, but many communities do not have adequate access to timely laboratory services. Geographic dispersion of small populations across islands and other rural and remote settings presents a key barrier to testing access. In this Personal View, we describe a model for the implementation of decentralised COVID-19 point-of-care testing in remote locations by use of the GeneXpert platform, which has been successfully scaled up in remote Aboriginal and Torres Strait Islander communities across Australia. Implementation of the decentralised point-of-care testing model should be considered for communities in need, especially those that are undertested and socially vulnerable. The decentralised testing model should be part of the core global response towards suppressing COVID-19. Many of the protocols and systems established are also relevant for high-performing antigen-based rapid diagnostic tests. Although registered by several health authorities, many tests are less sensitive than PCR, ranging from 0% to 94% (average 56%).34,35 However, a test with a sensitivity of 90% is better than no test at all, particularly if it can be scaled up. Two new funding initiatives (WHO’s Access to COVID-19 Tools Accelerator and the National Institutes of Health’s Rapid Acceleration of Diagnostics) aim to accelerate equitable access to POC PCR tests and high-performing rapid diagnostic tests.36,37 In October, 2020, WHO listed two rapid diagnostic tests as emergency use for detecting SARS-CoV-2, and announced a partnership to ensure that 120 million of these tests are available for low-income and middleincome countries.38 Overall, decentralised POC testing models could enable rapid public health responses, minimise further transmission and adverse patient outcomes, and reduce the burden on secondary and tertiary health facilities. Further investment to maximise the supply of POC tests and associated consumables is urgently needed. hTTps://doi.org/10.1016/S1473-3099(20)30859-8 Cepheid GeneXpert operates within the Danaher family of Operating Companies.
wan
06/1/2021
07:49
Is it not likely that a major holder selling would find a fund manager that wants to buy? This would avoid disturbing the main market and save money all round.
faz
06/1/2021
06:26
Thanks Rivaldo. It keeps us guessing but overall I still think Liontrust have mopped up substantially more than 1.2% of EKF, which is only the difference between the 4th and the 5th January. The RNS says the threshold was crossed 9th Dec and also shows previous holding as N/A (below 3%). For interest, in the AR, as at 6 April 2020, neither Liontrust, nor Octopus featured in the list of interests of 3% or more (page 19) - hTTps://www.ekfdiagnostics.com/res/Annual%20report%202019%20Digital%20Version.pdf Comparing the two lists, Octopus and Liontrust have clearly been recent buyers. Canaccord Genuity topped up a tad, but William Pippin 3.57% (founder/owner of Stanbio Labs, and when I last checked he was significantly into his retirement years) and Chelverton Asset Management 3.41% have both moved below 3% (or sold out). So, those last two look to have been a notable source of selling, and it will be interesting to see if the overhang has expired, or indeed if other funds adjust or increase their holdings, or indeed come onto the substantial shareholder register for the first time.
wan
05/1/2021
22:52
Great to see Liontrust going above 5%. To clarify, the EKF web site has Liontrust with 4.05%, or 18.41m shares, so they've now bought almost another 5.5m shares, i.e another 1.2% of EKF: Https://www.ekfdiagnostics.com/company-information.html
rivaldo
Chat Pages: Latest  123  122  121  120  119  118  117  116  115  114  113  112  Older
ADVFN Advertorial
Your Recent History
LSE
EKF
Ekf Diagno..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210423 11:40:44